Incidence and Risk of Oxaliplatin-Induced Hypersensitivity in Patients with Asymptomatic Prior Exposure: A Prospective Observational Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence and Risk of Oxaliplatin-Induced Hypersensitivity in Patients with Asymptomatic Prior Exposure: A Prospective Observational Study

Published:2018-09 Issue:5 Volume:6 Page:1642-1648.e2
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Sohn Kyoung-Hee,Kang Dong-Yoon,Kim Ju-Young,Lee Suh-Young,Lee Kyung-Hun^ORCID,Han Sae-Won,Kang Hye-Ryun

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference30 articles.

1. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial;Rothenberg;J Clin Oncol,2003

2. Capecitabine in combination with oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer;Park;Cancer Chemother Pharmacol,2008

3. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial;Bang;Lancet,2012

4. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;André;N Engl J Med,2004

5. Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions;Shao;J Formos Med Assoc,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Misdiagnosis of severe and atypical oxaliplatin‑related hypersensitivity reaction following chemotherapy combined with PD‑1 inhibitor: A case report and literature review;Oncology Letters;2024-07-23

2. High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy;International Immunopharmacology;2024-03

3. Clinical characteristics and risk factors for oxaliplatin hypersensitivity reactions in patients with colorectal cancer;Journal of Oncology Pharmacy Practice;2023-12-12

4. Cytokine profiling, pretreatment with anakinra, and tolerance development in platinum-induced mixed hypersensitivity reactions;Annals of Allergy, Asthma & Immunology;2023-10

5. Oxaliplatin-Related Hypersensitivity Reactions: A Single Institution Series and Literature Review;Biomedicines;2022-12-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3